"…then you'd have an approved drug, with full CM

"…then you'd have an approved drug, with full CMC and safety review, that could be expanded into COVID use."

So, if leronlimab gets approved for HIV and/or cancer first. Couldn't doctors prescribe it "off label" for COVID in the interim?